SUMMARY Beyond Air (NASDAQ:XAIR) reported substantial GAAP revenue growth for FY2025, driven primarily by new and renewed U.S. hospital contracts for its LungFit platform, and signaled increased ...

Beyond Air (NASDAQ:XAIR) stock is dropping on Tuesday after the commercial-stage medical device and biopharmaceutical company announced its latest earnings results. The bad news for XAIR stock starts ...

Beyond Air (NASDAQ:XAIR) just reported results for the first quarter of 2025. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports ...

Good afternoon, and welcome to the Beyond Air financial results call for the fiscal quarter ended September 30, 2025. [Operator Instructions] And now I would like to turn the call over to Garth ...

) has been revised to $9.18 / share. This is a decrease of 14.29% from the prior estimate of $10.71 dated November 7, 2025. The price target is an average of many targets provided by analysts. The ...

In this article we are going to use hedge fund sentiment as a tool and determine whether Beyond Air, Inc. (NASDAQ:XAIR) is a good investment right now. We like to analyze hedge fund sentiment before ...